Literature DB >> 27913903

Amyotrophic lateral sclerosis and myasthenia gravis: association or chance occurrence?

Silvia de Pasqua1, Francesco Cavallieri2, Roberto D'Angelo3, Fabrizio Salvi4, Nicola Fini2, Roberto D'Alessandro4, Rita Rinaldi3, Antonio Fasano2, Jessica Mandrioli5.   

Abstract

Very few cases of patients with myasthenia gravis (MG) who later developed amyotrophic lateral sclerosis (ALS) have been described, although some studies showed that significantly more cases than expected have ALS associated with a prior diagnosis of autoimmune diseases. Our aim was to investigate whether the association of ALS and MG was higher than expected in a population-based study and to describe the clinical features characterizing these patients. In Emilia Romagna Region of Italy, a prospective registry has been collecting all incident ALS cases since 1.1.2009. For each patient, detailed clinical information is collected by caring physicians, including comorbidities. From 1.1.2009 to 31.12.2014, 671 patients were diagnosed with ALS; five patients (0.75%) were also affected by MG. Considering Western Countries incidence rates the occurrence of both the diseases should be a really exceptional event (7.5/109), compared to our findings (1.87/107) (p < 0.01). Patients with ALS and MG had more frequently a bulbar onset and a fast progressive course. These cases of ALS after MG raise the possibility of potential shared immunological dysfunctions, which may be expression of common pathogenic mechanisms, as well as of shared disease-course modulating events.

Entities:  

Keywords:  Amyotrophic lateral sclerosis; Immune-mediated disorders; Immunological dysfunction; Myasthenia gravis; Regulatory T lymphocytes

Mesh:

Year:  2016        PMID: 27913903     DOI: 10.1007/s10072-016-2787-3

Source DB:  PubMed          Journal:  Neurol Sci        ISSN: 1590-1874            Impact factor:   3.307


  11 in total

1.  Protective effects of an anti-inflammatory cytokine, interleukin-4, on motoneuron toxicity induced by activated microglia.

Authors:  Weihua Zhao; Wenjie Xie; Qin Xiao; David R Beers; Stanley H Appel
Journal:  J Neurochem       Date:  2006-10-02       Impact factor: 5.372

Review 2.  The incidence of myasthenia gravis: a systematic literature review.

Authors:  Anita McGrogan; Samantha Sneddon; Corinne S de Vries
Journal:  Neuroepidemiology       Date:  2010-02-02       Impact factor: 3.282

3.  Myasthenia gravis and amyotrophic lateral sclerosis: A pathogenic overlap.

Authors:  Håvard Torvik Gotaas; Geir Olve Skeie; Nils Erik Gilhus
Journal:  Neuromuscul Disord       Date:  2016-03-28       Impact factor: 4.296

4.  Unusual association of amyotrophic lateral sclerosis and myasthenia gravis: A dysregulation of the adaptive immune system?

Authors:  Maria Del Mar Amador; Nadia Vandenberghe; Nawel Berhoune; Jean-Philippe Camdessanché; Sophie Gronier; Emilien Delmont; Claude Desnuelle; Pascal Cintas; Sophie Pittion; Sarah Louis; Sophie Demeret; Timothée Lenglet; Vincent Meininger; François Salachas; Pierre-François Pradat; Gaëlle Bruneteau
Journal:  Neuromuscul Disord       Date:  2016-03-29       Impact factor: 4.296

5.  Epidemiology of amyotrophic lateral sclerosis in Emilia Romagna Region (Italy): A population based study.

Authors:  Jessica Mandrioli; Sara Biguzzi; Carlo Guidi; Elisabetta Venturini; Elisabetta Sette; Emilio Terlizzi; Alessandro Ravasio; Mario Casmiro; Fabrizio Salvi; Rocco Liguori; Romana Rizzi; Vladimiro Pietrini; Elisabetta Chierici; Mario Santangelo; Enrico Granieri; Vittoria Mussuto; Annamaria Borghi; Rita Rinaldi; Nicola Fini; Eleni Georgoulopoulou; Silvia De Pasqua; Marco Vinceti; Francesca Bonvicini; Salvatore Ferro; Roberto D'Alessandro
Journal:  Amyotroph Lateral Scler Frontotemporal Degener       Date:  2014-02-07       Impact factor: 4.092

Review 6.  Myasthenia gravis: a comprehensive review of immune dysregulation and etiological mechanisms.

Authors:  Sonia Berrih-Aknin; Rozen Le Panse
Journal:  J Autoimmun       Date:  2014-01-03       Impact factor: 7.094

7.  CD4+CD25+Foxp3+ regulatory T cells induce alternative activation of human monocytes/macrophages.

Authors:  Machteld M Tiemessen; Ann L Jagger; Hayley G Evans; Martijn J C van Herwijnen; Susan John; Leonie S Taams
Journal:  Proc Natl Acad Sci U S A       Date:  2007-11-27       Impact factor: 11.205

8.  Regulatory T-lymphocytes mediate amyotrophic lateral sclerosis progression and survival.

Authors:  Jenny S Henkel; David R Beers; Shixiang Wen; Andreana L Rivera; Karen M Toennis; Joan E Appel; Weihua Zhao; Dan H Moore; Suzanne Z Powell; Stanley H Appel
Journal:  EMBO Mol Med       Date:  2012-11-09       Impact factor: 12.137

9.  LRP4 antibodies in serum and CSF from amyotrophic lateral sclerosis patients.

Authors:  John S Tzartos; Paraskevi Zisimopoulou; Michael Rentzos; Nikos Karandreas; Vasiliki Zouvelou; Panagiota Evangelakou; Anastasios Tsonis; Thomas Thomaidis; Giuseppe Lauria; Francesca Andreetta; Renato Mantegazza; Socrates J Tzartos
Journal:  Ann Clin Transl Neurol       Date:  2013-12-30       Impact factor: 4.511

10.  Autoimmune disease preceding amyotrophic lateral sclerosis: an epidemiologic study.

Authors:  Martin R Turner; Raph Goldacre; Sreeram Ramagopalan; Kevin Talbot; Michael J Goldacre
Journal:  Neurology       Date:  2013-08-14       Impact factor: 9.910

View more
  7 in total

1.  Ptosis and bulbar onset: an unusual phenotype of familial ALS?

Authors:  Fabiola De Marchi; L Corrado; E Bersano; M F Sarnelli; V Solara; S D'Alfonso; R Cantello; L Mazzini
Journal:  Neurol Sci       Date:  2017-11-13       Impact factor: 3.307

2.  Huntington's disease with comorbid myasthenia gravis: a case report.

Authors:  S Chatzikonstantinou; I Dagklis; D Kazis; E Karantali; S Bostantjopoulou
Journal:  Hippokratia       Date:  2019 Jan-Mar       Impact factor: 0.471

3.  News on the journal Neurological Sciences in 2017.

Authors:  Ilaria Di Donato; Antonio Federico
Journal:  Neurol Sci       Date:  2018-01       Impact factor: 3.307

4.  Amyotrophic Lateral Sclerosis and Myasthenia Gravis Overlap Syndrome: A Review of Two Cases and the Associated Literature.

Authors:  Hongfei Tai; Liying Cui; Yuzhou Guan; Mingsheng Liu; Xiaoguang Li; Yan Huang; Jing Yuan; Dongchao Shen; Dawei Li; Feifei Zhai
Journal:  Front Neurol       Date:  2017-05-22       Impact factor: 4.003

5.  Late-onset Myasthenia Gravis Accompanied by Amyotrophic Lateral Sclerosis with Antibodies against the Acetylcholine Receptor and Low-density Lipoprotein Receptor-related Protein 4.

Authors:  Keiko Ohnari; Kazumasa Okada; Osamu Higuchi; Hidenori Matsuo; Hiroaki Adachi
Journal:  Intern Med       Date:  2018-10-15       Impact factor: 1.271

6.  Very Early Involvement of Innate Immunity in Peripheral Nerve Degeneration in SOD1-G93A Mice.

Authors:  Daniela Francesca Angelini; Federica De Angelis; Valentina Vacca; Eleonora Piras; Chiara Parisi; Michele Nutini; Alida Spalloni; Francesca Pagano; Patrizia Longone; Luca Battistini; Flaminia Pavone; Sara Marinelli
Journal:  Front Immunol       Date:  2020-11-20       Impact factor: 7.561

7.  Excessive endosomal TLR signaling causes inflammatory disease in mice with defective SMCR8-WDR41-C9ORF72 complex function.

Authors:  William McAlpine; Lei Sun; Kuan-Wen Wang; Aijie Liu; Ruchi Jain; Miguel San Miguel; Jianhui Wang; Zhao Zhang; Braden Hayse; Sarah Grace McAlpine; Jin Huk Choi; Xue Zhong; Sara Ludwig; Jamie Russell; Xiaoming Zhan; Mihwa Choi; Xiaohong Li; Miao Tang; Eva Marie Y Moresco; Bruce Beutler; Emre Turer
Journal:  Proc Natl Acad Sci U S A       Date:  2018-11-15       Impact factor: 12.779

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.